Skip to content
Home/Companies/HealthTech/Ametris (ActiGraph)
A(

Ametris (ActiGraph)

HealthTech·US·Exited 2026·Held 6yr

Ametris (ActiGraph) is a healthcare it company, headquartered in United States.

Entry
2020
Hold
6yr
Exit
2026
Est. EV
–

Who owns Ametris (ActiGraph)?

Ametris (ActiGraph) was owned by ARCHIMED through MED Platform I (2019 vintage) from 2020 to 2026, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Platform I · 2019 · Buyout

Key facts

HQUnited States
SectorHealthcare IT
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2026

More from MED Platform I

Other portfolio companies in the same fund.

CARSO
Active
MedTechFrance· 2021
Ad-Tech Medical Instrument
Exited 2024
MedTechUS· 2020
to
NAMSA
Active
MedTechUS· 2020
ZYTOMICS
Active
MedTechGermany· 2020
Bomi Group
Exited 2023
MedTechItaly· 2019
to
DIESSE
Exited 2025
MedTechItaly· 2019
to

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

CIGA Healthcare
Active
Clarendon Fund ManagersUK
Paladin
Active
Ring CapitalFrance
Theraclion
Exited 2014
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings